OxFORD Asset Management LLP grew its stake in Mallinckrodt PLC (NYSE:MNK) by 68.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 84,230 shares of the company’s stock after purchasing an additional 34,154 shares during the period. OxFORD Asset Management LLP owned about 0.09% of Mallinckrodt worth $3,070,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently bought and sold shares of MNK. Municipal Employees Retirement System of Michigan boosted its position in Mallinckrodt by 24.5% during the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 5,640 shares of the company’s stock worth $253,000 after buying an additional 1,110 shares during the period. Great West Life Assurance Co. Can boosted its position in Mallinckrodt by 7.6% during the 2nd quarter. Great West Life Assurance Co. Can now owns 91,049 shares of the company’s stock worth $4,074,000 after buying an additional 6,444 shares during the period. Sei Investments Co. boosted its position in Mallinckrodt by 237.7% during the 2nd quarter. Sei Investments Co. now owns 19,557 shares of the company’s stock worth $876,000 after buying an additional 13,765 shares during the period. Retirement Systems of Alabama boosted its position in Mallinckrodt by 10.3% during the 2nd quarter. Retirement Systems of Alabama now owns 153,397 shares of the company’s stock worth $6,874,000 after buying an additional 14,315 shares during the period. Finally, Advisor Partners LLC acquired a new stake in Mallinckrodt during the 2nd quarter worth approximately $242,000. Institutional investors own 97.40% of the company’s stock.
Several equities research analysts recently commented on the stock. ValuEngine downgraded shares of Mallinckrodt from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Jefferies Group cut their target price on shares of Mallinckrodt from $70.00 to $60.00 and set a “buy” rating on the stock in a research report on Friday, August 25th. BidaskClub upgraded shares of Mallinckrodt from a “strong sell” rating to a “sell” rating in a research report on Friday, August 25th. Cantor Fitzgerald set a $52.00 price target on shares of Mallinckrodt and gave the stock a “buy” rating in a report on Monday, October 2nd. Finally, Canaccord Genuity lowered shares of Mallinckrodt from a “buy” rating to a “hold” rating and lowered their price target for the stock from $77.00 to $40.00 in a report on Wednesday, October 4th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and nine have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $48.14.
Mallinckrodt (NYSE:MNK) last released its quarterly earnings data on Tuesday, November 7th. The company reported $1.97 earnings per share for the quarter, beating the consensus estimate of $1.80 by $0.17. The company had revenue of $793.90 million during the quarter, compared to analyst estimates of $808.93 million. Mallinckrodt had a net margin of 11.43% and a return on equity of 14.79%. Mallinckrodt’s revenue for the quarter was down 10.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.04 EPS. sell-side analysts forecast that Mallinckrodt PLC will post 7.2 earnings per share for the current year.
In related news, Director David R. Carlucci acquired 10,000 shares of the stock in a transaction dated Thursday, November 9th. The stock was bought at an average price of $21.83 per share, for a total transaction of $218,300.00. Following the purchase, the director now directly owns 26,020 shares of the company’s stock, valued at approximately $568,016.60. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Steven J. Romano acquired 2,000 shares of the stock in a transaction dated Monday, November 13th. The stock was bought at an average price of $21.96 per share, with a total value of $43,920.00. The disclosure for this purchase can be found here. Insiders bought a total of 30,460 shares of company stock valued at $659,486 in the last quarter. 0.77% of the stock is currently owned by company insiders.
COPYRIGHT VIOLATION NOTICE: “Mallinckrodt PLC (MNK) Shares Bought by OxFORD Asset Management LLP” was originally published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://stocknewstimes.com/2017/12/10/mallinckrodt-plc-mnk-shares-bought-by-oxford-asset-management-llp.html.
Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs.
Want to see what other hedge funds are holding MNK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mallinckrodt PLC (NYSE:MNK).
Receive News & Ratings for Mallinckrodt PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mallinckrodt PLC and related companies with MarketBeat.com's FREE daily email newsletter.